Page last updated: 2024-09-03

marimastat and dithiol

marimastat has been researched along with dithiol in 1 studies

Compound Research Comparison

Studies (marimastat)	Trials (marimastat)	Recent Studies (post-2010) (marimastat)	Studies (dithiol)	Trials (dithiol)	Recent Studies (post-2010) (dithiol)
215	28	53	208	0	86

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fujita, M; Inoue-Kitahashi, N; Kawatashiro, K; Masunaga, T; Oba, Y; Okamoto, Y; Otsuka, M; Oyama, M; Radwan, MO; Tateishi, H; Tateishi, M	1

Other Studies

1 other study(ies) available for marimastat and dithiol

Article	Year
A New Inhibitor of ADAM17 Composed of a Zinc-Binding Dithiol Moiety and a Specificity Pocket-Binding Appendage. Chemical & pharmaceutical bulletin, 2021, Volume: 69, Issue:11 Topics: ADAM10 Protein; ADAM17 Protein; Benzenesulfonamides; Humans; Hyaluronan Receptors; Hydroxamic Acids; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Toluene; Tumor Necrosis Factor-alpha; Zinc	2021

Article

Year

A New Inhibitor of ADAM17 Composed of a Zinc-Binding Dithiol Moiety and a Specificity Pocket-Binding Appendage.

Chemical & pharmaceutical bulletin, 2021, Volume: 69, Issue:11

Topics: ADAM10 Protein; ADAM17 Protein; Benzenesulfonamides; Humans; Hyaluronan Receptors; Hydroxamic Acids; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Toluene; Tumor Necrosis Factor-alpha; Zinc

2021